Home・Elenco Azioni・Boston Scientific Corp.

Boston Scientific Corp.

Chiusa

SettoreSettore sanitario

42.96 -0.28

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

42.78

Massimo

43.53

Metriche Chiave
By Trading Economics
Entrata	-437M 904M
Vendite	239M 5.4B
P/E Media del settore	19.352 56.597
EPS	0.86
Margine di Profitto	16.612
Dipendenti	59,000
EBITDA	-214M 1.4B

Dividendi
By Acuity
Utili prossimi	28 ott 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	1.6B 69B
Apertura precedente	43.24
Chiusura precedente	42.96

Notizie sul Sentiment di mercato

By Acuity

88%

12%

319 / 339 Classifica in Healthcare

Boston Scientific Corp. Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 set 2026, 23:01 UTC

Boston Scientific shares are trading higher in after-market hours. The U.S. budget deficit for August was $167 billion, narrower than expected.

10 set 2026, 23:31 UTC

Boston Scientific Corp shares are higher in after-market hours, though no specific news was identified for the price movement. The broader market also showed notable gains.

9 set 2026, 20:07 UTC

News

Social Media

Boston Scientific shares are advancing today following Citi's report on network restoration and BTIG's maintained Buy rating, despite a lowered price target of $56.

8 set 2026, 23:01 UTC

Social Media

Boston Scientific Corp shares rose in after-market trading, reflecting positive movement since Tuesday's close amid notable options activity discussed on social media.

4 set 2026, 23:05 UTC

Boston Scientific Corp shares are lower in after-market trading amid mixed economic signals, including a slight rise in unemployment and increased Treasury yields.

3 set 2026, 20:02 UTC

News

Macro Event

Boston Scientific Corp is under scrutiny after notifying customers about the removal of Infinion CX leads linked to serious injuries, contributing to a stock decline.

2 set 2026, 23:21 UTC

Boston Scientific shares are higher in after-market trading, despite no specific news. Weaker job growth data may influence Federal Reserve interest rate expectations.

1 set 2026, 23:06 UTC

Boston Scientific Corp shares are lower in after-market hours, fluctuating within a narrow range and remaining below the 20-day moving average. No specific news was identified.

31 ago 2026, 23:06 UTC

Boston Scientific shares are higher in after-market trading, with no specific news identified. Broader market sentiment reflects heightened expectations for a Federal Reserve rate hike.

28 ago 2026, 23:06 UTC

Boston Scientific Corp. shares traded roughly flat in after-market hours, with no specific news identified and a slight cumulative return of 0.01%.

27 ago 2026, 23:01 UTC

Boston Scientific Corp shares are higher in after-market hours. No specific company news was identified to explain the movement, amid broader labor market data.

26 ago 2026, 23:01 UTC

News

Boston Scientific shares rise in after-market hours, supported by positive market sentiment despite recent operational challenges from a cybersecurity incident affecting IT systems.

25 ago 2026, 23:01 UTC

Boston Scientific Corp shares are higher in after-market trading, amid a broader market reaction to a significant drop in crude oil prices.

24 ago 2026, 20:01 UTC

News

Boston Scientific Corp shares are lower amid broader market declines linked to geopolitical tensions and concerns over oil supply disruptions affecting investor sentiment.

22 ago 2026, 00:01 UTC

Boston Scientific Corp is trading higher in after-market hours, reflecting broader market gains despite no specific company news driving the movement.

21 ago 2026, 23:01 UTC

Boston Scientific shares are higher in after-market trading, positioned above their 20-day moving average and near the upper end of their one-month range.

20 ago 2026, 22:51 UTC

Boston Scientific shares are higher in after-market trading, reflecting a gain since Thursday's close and remaining above the 20-day moving average.

19 ago 2026, 20:02 UTC

Boston Scientific shares are higher as the Health Care Equipment sector shows strong momentum. The stock is trading with unusually high volume today.

18 ago 2026, 23:06 UTC

Boston Scientific Corp shares are trading higher in after-market hours, remaining above their 20-day moving average amid broader market pressures from rising bond yields.

17 ago 2026, 23:16 UTC

Boston Scientific shares are higher in after-market hours, showing a slight gain since Monday's close. The stock remains stable near its one-month range.

15 ago 2026, 00:01 UTC

Boston Scientific Corp shares are higher in after-market hours, continuing a trend of six consecutive sessions of gains. No specific news was identified for this movement.

14 ago 2026, 23:01 UTC

Boston Scientific Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions finishing higher. No specific news was identified.

13 ago 2026, 23:01 UTC

Social Media

Boston Scientific shares are higher in after-market trading, buoyed by social media discussions of the CEO's $9 million stock purchase amid a significant year-to-date decline.

12 ago 2026, 23:06 UTC

Boston Scientific Corp shares are modestly higher in after-market trading. The stock remains significantly above its 20-day moving average.

11 ago 2026, 23:41 UTC

Boston Scientific Corp shares are lower in after-market trading, showing unusual volatility and reflecting a broader trend of weakness since Tuesday's close.

10 ago 2026, 23:06 UTC

Boston Scientific shares are trading higher in after-market hours, amid mixed market sentiment influenced by geopolitical tensions, particularly concerning the Strait of Hormuz.

8 ago 2026, 00:01 UTC

Boston Scientific Corp shares are higher in after-market trading, reflecting gains since Friday's close and remaining above their 20-day moving average.

7 ago 2026, 23:21 UTC

Boston Scientific shares are higher in after-market hours following a Labor Department report showing a decline in non-farm payroll employment, reducing interest rate hike expectations.

6 ago 2026, 23:01 UTC

Boston Scientific Corp shares are higher during after-market hours, reflecting a generally strong performance backdrop amid resilient labor market data.

5 ago 2026, 23:02 UTC

Social Media

News

Boston Scientific Corp shares rose in after-market trading following CEO Mahoney's purchase of 186,240 shares at an average price of $48.33.

Confronto tra pari

Modifica del prezzo

Boston Scientific Corp. Previsione

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

21 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 21 che hanno fornito valutazioni azionarie a Boston Scientific Corp. - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

319 / 339 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.